Jackson Lab, Wuhan Frasergen Bioinformatics to Launch Tumor Research Facility in China | GenomeWeb

NEW YORK (GenomeWeb) – The Jackson Laboratory and Wuhan Frasergen Bioinformatics will create a cancer genomics research facility in China with the aim of developing new personalized treatments.

Under a memorandum of understanding, the companies plan to launch a facility in Wuhan, Hubei Province, which hosts a center for the Chinese Academy of Sciences, Jackson Lab said on Saturday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.